JP2024534926A5 - - Google Patents
Info
- Publication number
- JP2024534926A5 JP2024534926A5 JP2024514495A JP2024514495A JP2024534926A5 JP 2024534926 A5 JP2024534926 A5 JP 2024534926A5 JP 2024514495 A JP2024514495 A JP 2024514495A JP 2024514495 A JP2024514495 A JP 2024514495A JP 2024534926 A5 JP2024534926 A5 JP 2024534926A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163241358P | 2021-09-07 | 2021-09-07 | |
| US63/241,358 | 2021-09-07 | ||
| PCT/EP2022/074646 WO2023036745A1 (en) | 2021-09-07 | 2022-09-05 | Method and composition for inducing tolerance |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024534926A JP2024534926A (ja) | 2024-09-26 |
| JP2024534926A5 true JP2024534926A5 (https=) | 2025-09-09 |
| JPWO2023036745A5 JPWO2023036745A5 (https=) | 2025-09-09 |
Family
ID=83438688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024514495A Pending JP2024534926A (ja) | 2021-09-07 | 2022-09-05 | 寛容性を誘導するための方法及び組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20240285756A1 (https=) |
| EP (1) | EP4398929A1 (https=) |
| JP (1) | JP2024534926A (https=) |
| AU (1) | AU2022342702A1 (https=) |
| CA (1) | CA3228514A1 (https=) |
| MX (1) | MX2024002811A (https=) |
| WO (1) | WO2023036745A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024505194A (ja) * | 2021-01-25 | 2024-02-05 | ゼラリオン マルタ リミテッド | 寛容を誘導する方法及び組成物 |
| WO2025207763A1 (en) * | 2024-03-27 | 2025-10-02 | Zelarion Malta Limited | Method and composition for inducing tolerance of transplanted organ or tissue |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002098370A2 (en) | 2001-03-02 | 2002-12-12 | Medimmune, Inc. | Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders |
| AU2014221330B2 (en) * | 2013-02-26 | 2018-10-04 | The Board Of Trustees Of The Leland Stanford Junior University | Combined organ and hematopoietic cells for transplantation tolerance of grafts |
-
2022
- 2022-09-05 AU AU2022342702A patent/AU2022342702A1/en active Pending
- 2022-09-05 MX MX2024002811A patent/MX2024002811A/es unknown
- 2022-09-05 JP JP2024514495A patent/JP2024534926A/ja active Pending
- 2022-09-05 WO PCT/EP2022/074646 patent/WO2023036745A1/en not_active Ceased
- 2022-09-05 EP EP22776895.9A patent/EP4398929A1/en active Pending
- 2022-09-05 CA CA3228514A patent/CA3228514A1/en active Pending
-
2024
- 2024-01-26 US US18/424,381 patent/US20240285756A1/en not_active Abandoned
-
2025
- 2025-05-16 US US19/210,482 patent/US20250276061A1/en active Pending